Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
31.01
-1.59 (-4.86%)
At close: Oct 6, 2026, 4:00 PM EDT
30.99
-0.02 (-0.05%)
Pre-market: Oct 7, 2026, 6:43 AM EDT
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of $2.43 billion as of October 6, 2026. Its market cap has increased by 38.83% in one year.
Market Cap
2.43B
Enterprise Value
1.72B
1-Year Change
38.83%
Ranking
Category
Stock Price
$31.01
ChartMarket Cap Chart
Since March 10, 2008, Celldex Therapeutics's market cap has increased from $47.20M to $2.43B, an increase of 5,058.49%. That is a compound annual growth rate of 23.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.43B | 34.91% |
| Dec 31, 2025 | 1.80B | 7.65% |
| Dec 31, 2024 | 1.68B | -10.56% |
| Dec 29, 2023 | 1.87B | -10.70% |
| Dec 30, 2022 | 2.10B | 16.42% |
| Dec 31, 2021 | 1.80B | 160.11% |
| Dec 31, 2020 | 693.20M | 1,825.56% |
| Dec 31, 2019 | 36.00M | 5.57% |
| Dec 31, 2018 | 34.10M | -91.17% |
| Dec 29, 2017 | 386.20M | 7.76% |
| Dec 30, 2016 | 358.40M | -76.83% |
| Dec 31, 2015 | 1.55B | -5.39% |
| Dec 31, 2014 | 1.64B | -16.73% |
| Dec 31, 2013 | 1.96B | 372.13% |
| Dec 31, 2012 | 415.90M | 262.28% |
| Dec 30, 2011 | 114.80M | -13.10% |
| Dec 31, 2010 | 132.10M | -10.50% |
| Dec 31, 2009 | 147.60M | 17.99% |
| Dec 31, 2008 | 125.10M | 165.04% |
| Mar 10, 2008 | 47.20M | - |
View and export this data all the way back to 2008. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.87B |
| MBX Biosciences | 2.83B |
| Precigen | 2.77B |
| NewAmsterdam Pharma Company | 2.73B |
| Recursion Pharmaceuticals | 2.57B |
| Beam Therapeutics | 2.56B |
| Disc Medicine | 2.43B |
| Immunome | 2.40B |